Nidhi Dwivedi1,2, Shixin Tao1,2, Abeda Jamadar1,2, Sonali Sinha1,2, Christianna Howard1,2, Darren P Wallace1,2, Timothy A Fields1,3, Andrew Leask4, James P Calvet1,5, Reena Rao6,2. 1. The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas. 2. Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas. 3. Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas. 4. School of Dentistry, University of Saskatchewan, Saskatoon, SK, Canada. 5. Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas. 6. The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas rrao@kumc.edu.
Abstract
BACKGROUND: Fibrosis is a major cause of loss of renal function in autosomal dominant polycystic kidney disease (ADPKD). In this study, we examined whether vasopressin type-2 receptor (V2R) activity in cystic epithelial cells can stimulate interstitial myofibroblasts and fibrosis in ADPKD kidneys. METHODS: We treated Pkd1 gene knockout (Pkd1KO) mice with dDAVP, a V2R agonist, for 3 days and evaluated the effect on myofibroblast deposition of extracellular matrix (ECM). We also analyzed the effects of conditioned media from primary cultures of human ADPKD cystic epithelial cells on myofibroblast activation. Because secretion of the profibrotic connective tissue growth factor (CCN2) increased significantly in dDAVP-treated Pkd1KO mouse kidneys, we examined its role in V2R-dependent fibrosis in ADPKD as well as that of yes-associated protein (YAP). RESULTS: V2R stimulation using dDAVP increased the renal interstitial myofibroblast population and ECM deposition. Similarly, conditioned media from human ADPKD cystic epithelial cells increased myofibroblast activation in vitro, suggesting a paracrine mechanism. Renal collecting duct-specific gene deletion of CCN2 significantly reduced cyst growth and myofibroblasts in Pkd1KO mouse kidneys. We found that YAP regulates CCN2, and YAP inhibition or gene deletion reduces renal fibrosis in Pkd1KO mouse kidneys. Importantly, YAP inactivation blocks the dDAVP-induced increase in myofibroblasts in Pkd1KO kidneys. Further in vitro studies showed that V2R regulates YAP by an ERK1/2-dependent mechanism in human ADPKD cystic epithelial cells. CONCLUSIONS: Our results demonstrate a novel mechanism by which cystic epithelial cells stimulate myofibroblasts in the pericystic microenvironment, leading to fibrosis in ADPKD. The V2R-YAP-CCN2 cell signaling pathway may present a potential therapeutic target for fibrosis in ADPKD.
BACKGROUND:Fibrosis is a major cause of loss of renal function in autosomal dominant polycystic kidney disease (ADPKD). In this study, we examined whether vasopressin type-2 receptor (V2R) activity in cystic epithelial cells can stimulate interstitial myofibroblasts and fibrosis in ADPKD kidneys. METHODS: We treated Pkd1 gene knockout (Pkd1KO) mice with dDAVP, a V2R agonist, for 3 days and evaluated the effect on myofibroblast deposition of extracellular matrix (ECM). We also analyzed the effects of conditioned media from primary cultures of human ADPKD cystic epithelial cells on myofibroblast activation. Because secretion of the profibrotic connective tissue growth factor (CCN2) increased significantly in dDAVP-treated Pkd1KO mouse kidneys, we examined its role in V2R-dependent fibrosis in ADPKD as well as that of yes-associated protein (YAP). RESULTS: V2R stimulation using dDAVP increased the renal interstitial myofibroblast population and ECM deposition. Similarly, conditioned media from human ADPKD cystic epithelial cells increased myofibroblast activation in vitro, suggesting a paracrine mechanism. Renal collecting duct-specific gene deletion of CCN2 significantly reduced cyst growth and myofibroblasts in Pkd1KO mouse kidneys. We found that YAP regulates CCN2, and YAP inhibition or gene deletion reduces renal fibrosis in Pkd1KO mouse kidneys. Importantly, YAP inactivation blocks the dDAVP-induced increase in myofibroblasts in Pkd1KO kidneys. Further in vitro studies showed that V2R regulates YAP by an ERK1/2-dependent mechanism in human ADPKD cystic epithelial cells. CONCLUSIONS: Our results demonstrate a novel mechanism by which cystic epithelial cells stimulate myofibroblasts in the pericystic microenvironment, leading to fibrosis in ADPKD. The V2R-YAP-CCN2 cell signaling pathway may present a potential therapeutic target for fibrosis in ADPKD.
Authors: Vicente E Torres; Xiaofang Wang; Qi Qian; Stefan Somlo; Peter C Harris; Vincent H Gattone Journal: Nat Med Date: 2004-02-29 Impact factor: 53.440
Authors: Tri Q Nguyen; Peggy Roestenberg; Frans A van Nieuwenhoven; Niels Bovenschen; Zeke Li; Leon Xu; Noelynn Oliver; Jan Aten; Jaap A Joles; Cecilia Vial; Enrique Brandan; Karen M Lyons; Roel Goldschmeding Journal: J Am Soc Nephrol Date: 2008-07-16 Impact factor: 10.121
Authors: Abeda Jamadar; Sreenath M Suma; Sijo Mathew; Timothy A Fields; Darren P Wallace; James P Calvet; Reena Rao Journal: Cell Death Dis Date: 2021-10-14 Impact factor: 8.469
Authors: Abeda Jamadar; Nidhi Dwivedi; Sijo Mathew; James P Calvet; Sufi M Thomas; Reena Rao Journal: Int J Mol Sci Date: 2022-07-09 Impact factor: 6.208
Authors: Ilianna Zoi; Antonios N Gargalionis; Kostas A Papavassiliou; Narjes Nasiri-Ansari; Christina Piperi; Efthimia K Basdra; Athanasios G Papavassiliou Journal: J Cell Mol Med Date: 2022-02-01 Impact factor: 5.310